Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001144204-11-052935
Filing Date
2011-09-14
Accepted
2011-09-14 12:44:51
Documents
7
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 10-Q v232679_10qa.htm 10-Q/A 32396
  Complete submission text file 0001144204-11-052935.txt   2850180

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT mhan-20110630.xml EX-101.INS 560329
3 XBRL TAXONOMY EXTENSION SCHEMA mhan-20110630.xsd EX-101.SCH 31696
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mhan-20110630_cal.xml EX-101.CAL 31545
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mhan-20110630_def.xml EX-101.DEF 102425
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE mhan-20110630_lab.xml EX-101.LAB 235747
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mhan-20110630_pre.xml EX-101.PRE 130174
Mailing Address 810 SEVENTH AVENUE 4TH FLOOR NEW YORK NY 10019
Business Address 810 SEVENTH AVENUE 4TH FLOOR NEW YORK NY 10019 (212) 582-3950
MANHATTAN PHARMACEUTICALS INC (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-32639 | Film No.: 111089881
SIC: 2834 Pharmaceutical Preparations